clonidine has been researched along with neuropeptide y (13-36) in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, X; Doughty, MB; Miller, DW; Misse, GA; Tessel, RE | 1 |
| Agnati, LF; Fuxe, K; Martire, M; Mores, N; Pistritto, G | 1 |
2 other study(ies) available for clonidine and neuropeptide y (13-36)
| Article | Year |
|---|---|
Characterization of vascular postsynaptic NPY receptor function and regulation and differential sensitivity of Y1 and Y2 receptor function to changes in extracellular calcium availability and prior in vitro peptide exposure.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Animals; Calcium; Clonidine; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Neuropeptide Y; Peptide Fragments; Peptides; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Synapses; Vasoconstrictor Agents | 1993 |
Presynaptic A2-adrenoceptors and neuropeptide Y Y2 receptors inhibit [3H]noradrenaline release from rat hypothalamic synaptosomes via different mechanisms.
Topics: 4-Aminopyridine; Animals; Calcium Channel Blockers; Clonidine; Hypothalamus; Male; Mollusk Venoms; Neuropeptide Y; Norepinephrine; omega-Conotoxin GVIA; Peptide Fragments; Peptides; Presynaptic Terminals; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Receptors, Neuropeptide Y; Synaptosomes; Time Factors | 1995 |